Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AddHope2: Liraglutide in CAD and Newly Diagnosed T2D
NCT01595789Phase 4Completed
- Start
- May 2012
- Primary completion
- Oct 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM). Started May 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01595789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01595789.